选择性Tau蛋白成像：. - Suppr

Selective Tau Imaging: .

作者信息

Villemagne Victor L

机构信息

Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Australia; Department of Medicine, Austin Health, University of Melbourne, Melbourne, Australia; and Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia

出版信息

J Nucl Med. 2018 Feb;59(2):175-176. doi: 10.2967/jnumed.117.198325. Epub 2017 Sep 21.

DOI:10.2967/jnumed.117.198325

PMID:28935837

Abstract

摘要

相似文献

Selective Tau Imaging: .

J Nucl Med. 2018 Feb;59(2):175-176. doi: 10.2967/jnumed.117.198325. Epub 2017 Sep 21.

HIV encephalitis with subcortical tau deposition: imaging pathology in vivo using F-18 THK 5117.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2456-2457. doi: 10.1007/s00259-016-3473-7. Epub 2016 Aug 3.

Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future.

J Med Chem. 2015 Jun 11;58(11):4365-82. doi: 10.1021/jm5017544. Epub 2015 Feb 25.

Preclinical Evaluation of F-JNJ64349311, a Novel PET Tracer for Tau Imaging.

J Nucl Med. 2017 Jun;58(6):975-981. doi: 10.2967/jnumed.116.185199. Epub 2017 Feb 23.

Characteristics of Tau and Its Ligands in PET Imaging.

Biomolecules. 2016 Jan 6;6(1):7. doi: 10.3390/biom6010007.

PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.

J Nucl Med. 2015 Sep;56(9):1359-65. doi: 10.2967/jnumed.115.160127. Epub 2015 Jul 16.

Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.

Methods Mol Biol. 2018;1750:221-229. doi: 10.1007/978-1-4939-7704-8_15.

[Tau imaging].

Nihon Rinsho. 2016 Mar;74(3):404-9.

Developments in Tau PET Imaging.

Can J Neurol Sci. 2014 Sep;41(5):547-53. doi: 10.1017/cjn.2014.15.

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy.

Acta Neuropathol. 2017 Jan;133(1):149-151. doi: 10.1007/s00401-016-1650-1. Epub 2016 Nov 29.

引用本文的文献

Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning.

Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):2998-3007. doi: 10.1007/s00259-020-04897-6. Epub 2020 Jun 13.

Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters.

Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2666-2680. doi: 10.1007/s00259-020-04714-0. Epub 2020 Feb 13.

Current radiotracers to image neurodegenerative diseases.

EJNMMI Radiopharm Chem. 2019 Jul 26;4(1):17. doi: 10.1186/s41181-019-0070-7.

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.

Parametric methods for [F]flortaucipir PET.

J Cereb Blood Flow Metab. 2020 Feb;40(2):365-373. doi: 10.1177/0271678X18820765. Epub 2018 Dec 20.

The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.

Ann Neurol. 2019 Feb;85(2):181-193. doi: 10.1002/ana.25395. Epub 2019 Jan 21.

Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.

Front Neurosci. 2018 Aug 21;12:585. doi: 10.3389/fnins.2018.00585. eCollection 2018.

Neuroimaging-pathological correlations of [F]THK5351 PET in progressive supranuclear palsy.

Acta Neuropathol Commun. 2018 Jun 29;6(1):53. doi: 10.1186/s40478-018-0556-7.

Structure-Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology.

ACS Med Chem Lett. 2018 Apr 10;9(5):478-483. doi: 10.1021/acsmedchemlett.8b00092. eCollection 2018 May 10.

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.

Alzheimers Res Ther. 2017 Dec 11;9(1):96. doi: 10.1186/s13195-017-0325-z.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Selective Tau Imaging: .

J Nucl Med. 2018 Feb;59(2):175-176. doi: 10.2967/jnumed.117.198325. Epub 2017 Sep 21.

HIV encephalitis with subcortical tau deposition: imaging pathology in vivo using F-18 THK 5117.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2456-2457. doi: 10.1007/s00259-016-3473-7. Epub 2016 Aug 3.

Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future.

J Med Chem. 2015 Jun 11;58(11):4365-82. doi: 10.1021/jm5017544. Epub 2015 Feb 25.

Preclinical Evaluation of F-JNJ64349311, a Novel PET Tracer for Tau Imaging.

J Nucl Med. 2017 Jun;58(6):975-981. doi: 10.2967/jnumed.116.185199. Epub 2017 Feb 23.

Characteristics of Tau and Its Ligands in PET Imaging.

Biomolecules. 2016 Jan 6;6(1):7. doi: 10.3390/biom6010007.

PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.

J Nucl Med. 2015 Sep;56(9):1359-65. doi: 10.2967/jnumed.115.160127. Epub 2015 Jul 16.

Quantification of Tau Load in Alzheimer's Disease Clinical Trials Using Positron Emission Tomography.

Methods Mol Biol. 2018;1750:221-229. doi: 10.1007/978-1-4939-7704-8_15.

[Tau imaging].

Nihon Rinsho. 2016 Mar;74(3):404-9.

Developments in Tau PET Imaging.

Can J Neurol Sci. 2014 Sep;41(5):547-53. doi: 10.1017/cjn.2014.15.

Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy.

Acta Neuropathol. 2017 Jan;133(1):149-151. doi: 10.1007/s00401-016-1650-1. Epub 2016 Nov 29.

引用本文的文献

Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning.

Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):2998-3007. doi: 10.1007/s00259-020-04897-6. Epub 2020 Jun 13.

Eur J Nucl Med Mol Imaging. 2020 Oct;47(11):2666-2680. doi: 10.1007/s00259-020-04714-0. Epub 2020 Feb 13.

Current radiotracers to image neurodegenerative diseases.

EJNMMI Radiopharm Chem. 2019 Jul 26;4(1):17. doi: 10.1186/s41181-019-0070-7.

Deep and Frequent Phenotyping study protocol: an observational study in prodromal Alzheimer's disease.

BMJ Open. 2019 Mar 23;9(3):e024498. doi: 10.1136/bmjopen-2018-024498.

Parametric methods for [F]flortaucipir PET.

J Cereb Blood Flow Metab. 2020 Feb;40(2):365-373. doi: 10.1177/0271678X18820765. Epub 2018 Dec 20.

The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.

Ann Neurol. 2019 Feb;85(2):181-193. doi: 10.1002/ana.25395. Epub 2019 Jan 21.

Imaging Protein Misfolding in the Brain Using β-Sheet Ligands.

Front Neurosci. 2018 Aug 21;12:585. doi: 10.3389/fnins.2018.00585. eCollection 2018.

Neuroimaging-pathological correlations of [F]THK5351 PET in progressive supranuclear palsy.

Acta Neuropathol Commun. 2018 Jun 29;6(1):53. doi: 10.1186/s40478-018-0556-7.

Structure-Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology.

ACS Med Chem Lett. 2018 Apr 10;9(5):478-483. doi: 10.1021/acsmedchemlett.8b00092. eCollection 2018 May 10.

Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.

Alzheimers Res Ther. 2017 Dec 11;9(1):96. doi: 10.1186/s13195-017-0325-z.

Selective Tau Imaging: .

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Selective Tau Imaging: .

作者信息

机构信息

出版信息

相似文献

引用本文的文献